Future of the Heart | Tucker L. Hamilton | TEDxBoston

Key Concepts:

• Heartbeat as a fundamental sign of life
• Cardiovascular disease and its prevalence
• Heart transplant as a life-saving procedure
• "Heart in a box" technology for heart preservation and transportation
• Funnel web spider venom-derived drug for heart protection
• Left Ventricular Assist Device (LVAD) as a mechanical heart pump
• Total Artificial Heart (TAH) as a complete heart replacement
• The role of technology and AI in cardiovascular care
• Importance of empathy and diversity in data-driven healthcare

1. The Significance of the Heartbeat and Cardiovascular Disease:

• The human heartbeat is presented as a fundamental aspect of life, starting from early embryonic development.
• Cardiovascular disease is highlighted as a major health concern, affecting a significant portion of the population (1 in 20).
• The emotional impact of heart-related issues is acknowledged, referencing "heartbreak" and the prevalence of heart conditions in families.

2. Heart Transplants and the "Heart in a Box" Technology:

• Heart transplant is described as "the ultimate gift of life," prolonging a recipient's life by almost 20 years.
• The limitations of traditional heart preservation methods (ice storage) are discussed.
• The "heart in a box" technology, pioneered at St Vincent's Hospital and the Victor Chang Cardiac Research Institute, is introduced as a solution for longer-distance heart transportation.
  • This technology allows the heart to pump while outside the body, enabling monitoring and assessment of its condition.
  • Parameters like lactic acid levels and angiograms can be assessed while the heart is in the box.

3. Augmenting Heart Function: The Funnel Web Spider Venom:

• The use of a protein derived from the funnel web spider venom to protect heart muscle cells is presented as an innovative approach.
• This protein blocks the "suicide signal" triggered by lactic acid buildup in damaged heart tissue (e.g., after a heart attack or during heart preservation).
• The potential for administering this medication in remote areas by ambulance officers is mentioned.

4. Bodies Living Without Hearts: LVADs and Total Artificial Hearts:

• The basic function of the heart as a pump with chambers, valves, and arteries is explained.
• Despite medical advancements, cardiovascular disease remains a leading cause of death (18 million worldwide).
• Left Ventricular Assist Devices (LVADs) are introduced as mechanical pumps that assist the left ventricle.
  • Patients with LVADs may not have a palpable pulse, and the device's whirring sound is audible with a stethoscope.
• The development of the Total Artificial Heart (TAH) is presented as a significant innovation.
  • The story of Daniel Tims, who developed a titanium heart after his father's death from heart disease, is shared.
  • A man lived 100 days with an entirely titanium heart before receiving a transplant.
  • The titanium heart is described as tiny with a 4-hour battery life.

5. The Future of Cardiovascular Care: Smart Hearts and Reconnecting to Our Smarts:

• The integration of technology in cardiovascular care is emphasized, including wearables, artificial intelligence (AI), and the Internet of Things (IoT).
• AI is already capable of diagnosing heart conditions on heart ultrasounds better than humans.
• The importance of designing data sets with empathy and diversity is highlighted.
• The speaker emphasizes the need to "reconnect to our own smarts" and use technology thoughtfully.

6. Conclusion:

• The speaker reiterates that innovation in cardiovascular care has made it possible for hearts to live outside of bodies and bodies to live without hearts.
• The key message is that innovation in the era of smart hearts must continue in the space between the beats.